Literature DB >> 14574288

Uvulopalatal flap for snoring on an outpatient basis.

Chairat Neruntarat1.   

Abstract

OBJECTIVE: Snoring is now seen as one end of a spectrum of sleep-related breathing disorders, and in its extreme form, snoring can cause obstructive sleep apnea syndrome. Since the introduction of uvulopalatopharyngoplasty, many other procedures have been introduced to alleviate palatal abnormalities seen in patients with obstructive sleep apnea syndrome. A reversible uvulopalatal flap (UPF) achieves the same results as the uvulopalatopharyngoplasty but with less postoperative discomfort. The purpose of this study was to assess the safety and efficacy of UPF for the treatment of simple snoring on an outpatient basis.
METHODS: UFP was performed on an outpatient basis under local anesthesia. The mucosa on the lingual surface of the uvula and soft palate was removed with cold knife dissection. The uvular tip was amputated. The uvula was reflected back toward the soft palate and sutured. Most of the patients were male with simple snoring by history and confirmed by polysomnographic study. Data on patients were compared from preoperative to postoperative assessment points. Statistic analysis was performed.
RESULTS: Fifty-six patients tolerated the procedure well, and it was performed in an average of 20 minutes. Patients had a mean age of 48 years and a mean body mass index of 26.5 kg/m(2). The mean follow-up was 14 months (range, 12 to 20 months). Significant improvement was observed in snoring scale (8.2 +/- 3.4 versus 2.6 +/- 1.4, P < 0.05). Mean snoring index decreased from 245.8 +/- 40.8 to 42.5 +/- 20.7 events/hr (P < 0.001). The correlations between the changes in the subjective and objective snoring assessments were statistically significant. Postoperative complications included transient nasal regurgitation (4%) and foreign body sensation (2%). Bleeding, dysphagia, infection, and nasopharyngeal stenosis were not observed. Most patients had mild to moderate pain (visual analog scale, </=7) for 5 to 7 days after the procedures. The overall success rate was 88%.
CONCLUSION: Snoring, as reported by subjective and objective results, decreased after UPF. It appears to be a safe and effective procedure, which can be easily performed under local anesthesia on an outpatient basis, in carefully selected patients.

Entities:  

Mesh:

Year:  2003        PMID: 14574288     DOI: 10.1016/S0194-59980300636-3

Source DB:  PubMed          Journal:  Otolaryngol Head Neck Surg        ISSN: 0194-5998            Impact factor:   5.591


  6 in total

1.  Effect of uvulopalatopharyngoplasty on retropalatal region.

Authors:  Hasan Tanyeri; Gediz Murat Serin; Elif Ayanoglu Aksoy; Senol Polat; Caglar Cuhadaroglu
Journal:  Eur Arch Otorhinolaryngol       Date:  2012-11-09       Impact factor: 2.503

2.  The relationship of the uvula with snoring and obstructive sleep apnea: a systematic review.

Authors:  Edward T Chang; Grace Baik; Carlos Torre; Scott E Brietzke; Macario Camacho
Journal:  Sleep Breath       Date:  2018-03-09       Impact factor: 2.816

3.  Preliminary findings from our experience in anterior palatoplasty for the treatment of obstructive sleep apnea.

Authors:  Andrea Marzetti; Massimiliano Tedaldi; Francesco Maria Passali
Journal:  Clin Exp Otorhinolaryngol       Date:  2013-03-08       Impact factor: 3.372

4.  Reconstructive procedures for disturbed functions within the upper airway: pharyngeal breathing/snoring.

Authors:  Thomas Verse
Journal:  GMS Curr Top Otorhinolaryngol Head Neck Surg       Date:  2005-09-28

5.  Hypoxia-mediated mechanism of MUC5AC production in human nasal epithelia and its implication in rhinosinusitis.

Authors:  Yoon-Ju Kim; Hyung-Ju Cho; Woo-Chul Shin; Hyun-Ah Song; Joo-Heon Yoon; Chang-Hoon Kim
Journal:  PLoS One       Date:  2014-05-19       Impact factor: 3.240

6.  Oxygen matters: hypoxia as a pathogenic mechanism in rhinosinusitis.

Authors:  Hyung-Ju Cho; Chang-Hoon Kim
Journal:  BMB Rep       Date:  2018-02       Impact factor: 4.778

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.